The advertisement promotes Danziten™ (nicotinib tablets), highlighting its inclusion in NCCN Clinical Practice Guidelines for oncology treatment of chronic myeloid leukemia (CML) and provides important safety information.
Creative Information
| CID: | 1f9897b4-3fad-42df-963f-e7b1db2e19cc |
| CRID: | 25_0y0acqgi |
| Domain: | gliadel.com |
| Seat: | TTD |
| Size: | 728x90 |
| Bid: | $2.35 |
| Timestamp: | 11/10/2025, 6:37:14 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/10/2025, 6:55:43 PM | 8.24s | |
| adomain_analysis | success | 11/10/2025, 8:32:57 PM | 4.36s | |
| adomain_capture | success | 11/10/2025, 8:32:52 PM | 0.13s | |
| ad_render | success | 11/10/2025, 6:55:35 PM | 33.85s | |
| brand_mapping | success | 11/10/2025, 6:55:38 PM | 2.98s | |
Analysis Results
Ad Format: banner
Brands: Gliadel
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1227.53 KB | ||||||||||||||||||||||
| Render Time: | 8.04 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1246.83 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


